![]() |
市場調查報告書
商品編碼
1754110
血管封閉裝置市場報告(按產品(發電機、儀器、配件)、應用(一般外科、腹腔鏡手術)、最終用戶(醫院和專科診所、門診手術中心)和地區)2025 年至 2033 年Vessel Sealing Devices Market Report by Product (Generators, Instruments, Accessories), Application (General Surgery, Laparoscopic Surgery), End User (Hospitals and Specialty Clinics, Ambulatory Surgical Centers), and Region 2025-2033 |
2024年,全球血管封閉設備市場規模達20億美元。展望未來, IMARC Group預計到2033年,該市場規模將達到35億美元,2025-2033年期間的複合年成長率(CAGR)為5.77%。慢性病盛行率的上升、手術器械(尤其是血管封閉設備)技術的進步,以及人們對微創手術日益成長的偏好,共同推動著該市場的發展。
慢性病盛行率上升
癌症、心血管疾病和肥胖等慢性疾病的發生率不斷上升,是血管封閉裝置市場成長的主要驅動力。由於這些疾病通常需要外科手術治療,因此對能夠提高手術效率和安全性的先進外科設備的需求也在不斷成長。根據美國疾病管制與預防中心的數據,美國約有1.29億人至少患有一種主要慢性疾病,包括心臟病、癌症、糖尿病、肥胖和高血壓。此外,美國十大主要死因中有五種與可預防和可治療的慢性疾病密切相關。血管封閉裝置在涉及大量組織操作和止血的手術中尤其重要,因為它們能夠持續封閉血管和組織束,減少術中失血和術後併發症。全球慢性疾病負擔的加重,加上人口老化,加劇了對外科治療的需求,從而推動了對有效血管封閉解決方案的需求。
微創手術的採用率不斷提高
創造良好血管封閉裝置市場前景的另一個關鍵因素是向微創手術 (MIS) 程序的過渡。根據美國國家醫學圖書館的數據,2017 年,共分析了 980 萬例住院主要手術室程序,其中 11.1% 為 MIS,2.5% 為機器人輔助,而 2018 年為 960 萬例住院手術室程序(11.2% 為 MIS,2.9% 為機器人輔助)。腹腔鏡和機器人手術等微創手術與傳統開放性手術相比具有多種優勢,包括術後疼痛更少、住院時間更短、恢復時間更快以及併發症發生率更低。血管封閉裝置對於 MIS 程序至關重要,因為它們能夠在有限的手術範圍內實現精確和成功的止血。微創手術在患者和醫療保健提供者中的普及導致對複雜血管封閉技術的需求增加。
醫療支出不斷上漲
全球醫療支出的增加和醫療基礎設施的持續發展是血管封閉設備市場的主要驅動力。根據醫療保險和醫療補助服務中心的數據,美國醫療保健支出成長 4.1%,到 2022 年將達到 4.5 兆美元,高於 2021 年 3.2% 的增幅。此外,2022 年,參保人口比例達到 92%(創歷史新高)。私人醫療保險投保人數增加了 290 萬人,醫療補助參保人數增加了 610 萬人。政府和私營部門在醫療機構方面的支出,尤其是在新興國家,正帶動配備尖端技術的現代化外科中心的建設。這種擴張提高了先進外科手術的可近性和可負擔性,增加了血管封閉設備的使用。此外,已開發國家和開發中國家都專注於改善手術效果和病人安全,這刺激了對高性能手術設備,尤其是血管封閉設備的需求。
儀器佔大部分市場佔有率
血管封閉器械廣泛應用於各種外科手術,包括一般外科、婦科、泌尿外科和心血管外科。它們能夠持續止血並防止術中失血,使其成為許多複雜微創手術的必備器械。這些器械能夠處理各種類型和大小的組織,並與各種外科手術相容,擴大了其應用範圍。因此,手術數量的增加也推動了對血管封閉器械的需求,並帶來了可觀的市場佔有率。根據印度國家醫學圖書館 2020 年發布的資料,印度人口為 88,273 人,每年共進行 4,642 例手術。其中,最常見的手術是白內障手術(22.8%)、剖腹產手術(3.8%)、骨折手術(3.27%)和疝氣手術(2.86%)。此外,44.2% 的手術屬於必要手術。
腹腔鏡手術佔據業界最大佔有率
先進的血管封閉技術顯著提高了腹腔鏡手術的精確度和安全性。這些技術使外科醫生能夠準確且快速地封閉動脈和組織束,從而減少失血和併發症風險。精準的封閉和切割控制可以減少溫度向鄰近組織的擴散,這對於腹腔鏡手術中精細且有限的區域尤其重要。這種高精度水準推動了血管封閉裝置在腹腔鏡手術中的廣泛應用。此外,腹腔鏡設備和血管封閉技術的進步也使其更加普及。整合切割和封閉功能、人體工學設計和改進的能量傳輸系統等創新功能顯著提高了血管封閉裝置的有效性。
醫院和專科診所是主要的細分市場
慢性病發生率的上升是推動醫院和專科診所發展的關鍵因素。根據美國疾病管制與預防中心的數據,美國約有1.29億人至少患有一種主要慢性病,例如心臟病、癌症、糖尿病、肥胖和高血壓。此外,美國十大主要死因中有五種與可預防和可治療的慢性病密切相關。過去20年,慢性病發生率穩定上升,預計這一趨勢還會持續。糖尿病、高血壓、癌症和呼吸系統疾病等慢性病需要持續的醫療照護、頻繁的監測和專科治療。這導致對能夠有效管理這些疾病的醫療服務和設施的需求激增。專注於糖尿病護理、腫瘤科、心臟科和肺科的專科診所正在擴張,以滿足慢性病患者的需求,這反過來又增加了對血管封閉設備的需求。
北美引領市場,佔據最大的血管密封裝置市場佔有率
該報告還對所有主要區域市場進行了全面分析,包括北美(美國和加拿大);歐洲(德國、法國、英國、義大利、西班牙、俄羅斯等);亞太地區(中國、日本、印度、韓國、澳洲、印尼等);拉丁美洲(巴西、墨西哥等);以及中東和非洲。報告指出,北美是血管封閉裝置最大的區域市場。
北美,尤其是美國,擁有世界上最先進的醫療體系之一。由平等機會研究基金會(FREOPP)發布的2021年世界醫療創新指數顯示,美國在全球醫療體系中排名第六。分析發現,美國在科學進步方面處於全球領先地位,但其醫療體系在財務上難以為繼。設備齊全的醫院、專科手術設施和診所的普及促進了血管封閉裝置等創新醫療技術的使用。此外,該地區的醫療體系在尖端設備和技術方面投入巨資,從而能夠提供高品質的外科護理。此外,公共和私營部門在醫療領域的高支出,也使得醫療技術和外科創新方面的投資成為可能。
The global vessel sealing devices market size reached USD 2.0 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 3.5 Billion by 2033, exhibiting a growth rate (CAGR) of 5.77% during 2025-2033. The market is propelled by rising prevalence of chronic diseases, technological advancements in surgical instruments, particularly in vessel sealing devices, and the increasing preference for minimally invasive surgeries.
Rising prevalence of chronic diseases
The rising frequency of chronic diseases like cancer, cardiovascular problems, and obesity is a major driver of the vessel sealing devices market growth. As these illnesses frequently require surgical procedures, there is an increased demand for sophisticated surgical equipment that can improve procedural efficacy and safety. As per Centers of Diseases Control and Prevention, an estimated 129 million people in the US have at least 1 major chronic disease including heart disease, cancer, diabetes, obesity, and hypertension. Besides, five of the top 10 leading causes of death in the US are, or are strongly associated with, preventable and treatable chronic diseases. Vessel sealing devices are especially important in procedures involving substantial tissue manipulation and hemostasis because they offer consistent sealing of blood vessels and tissue bundles, reducing intraoperative blood loss and postoperative problems. The growing burden of chronic diseases around the world, combined with the aging population, magnifies the need for surgical treatments, boosting the demand for effective vessel sealing solutions.
Increasing adoption of minimally invasive surgeries
Another key element creating a favorable vascular sealing devices market outlook is the transition to minimally invasive surgical (MIS) procedures. According to National Library of Medicine, in 2017, 9.8 million inpatient major operating room procedures were analyzed, of which 11.1% were MIS and 2.5% were robotic-assisted, compared with 9.6 million inpatient operating room procedures (11.2% MIS and 2.9% robotic-assisted) in 2018. Minimally invasive procedures, such as laparoscopic and robotic surgeries, have various advantages over traditional open surgeries, including less postoperative pain, shorter hospital stays, faster recovery times, and a lower chance of complications. Vessel sealing devices are essential for MIS procedures because they enable precise and successful hemostasis in limited surgical fields. The popularity of minimally invasive operations among patients and healthcare providers has led to increased demand for sophisticated vascular sealing technologies.
Rising healthcare expenditure
Increased healthcare spending and continued development of healthcare infrastructure worldwide are major drivers of the vessel sealing devices market. As per Centers for Medicare and Medicaid Services, U.S. health care spending grew 4.1% to reach $4.5 Trillion in 2022, faster than the increase of 3.2% in 2021. Besides, in 2022, the insured share of the population reached 92% (a historic high). Private health insurance enrollment increased by 2.9 million individuals and Medicaid enrollment increased by 6.1 million individuals. Government and private sector expenditures in healthcare facilities, particularly in emerging nations, are leading to the construction of modern surgery centers outfitted with cutting-edge technology. This expansion improves the accessibility and affordability of advanced surgical procedures, increasing the use of vessel sealing devices. Furthermore, the focus on improving surgical results and patient safety in both developed and developing nations encourages the demand for high-performance surgical equipment, particularly vascular sealing devices.
Instruments accounts for the majority of the market share
Vessel sealing instruments are utilized in many different surgical procedures, including general surgery, gynecology, urology, and cardiovascular surgery. Their ability to produce consistent hemostasis and prevent intraoperative blood loss makes them essential in many complex and minimally invasive operations. The adaptability of these devices in handling diverse tissue kinds and sizes, as well as their compatibility with various surgical procedures, broadens their use range. Hence, the increasing number of surgeries is escalating the demand for vessel sealing devices, resulting in a considerable market share. As per data published by National Library of Medicine in 2020, a total of 4642 surgeries were performed per year in India for a population of 88,273. Cataract (22.8%), caesareans (3.8%), surgeries for fractures (3.27%) and hernia (2.86%) were the most common surgeries. Moreover, 44.2% of surgeries belonged to essential surgeries.
Laparoscopic surgery holds the largest share of the industry
Advanced vascular sealing technologies considerably improve the precision and safety of laparoscopic surgery. These technologies enable surgeons to properly and swiftly seal blood arteries and tissue bundles, lowering blood loss and the risk of complications. The exact control over sealing and cutting decreases temperature diffusion to adjacent tissues, which is especially critical in the delicate and limited regions of laparoscopic surgery. This high level of precision drives the widespread adoption of vessel sealing devices in laparoscopic procedures. Besides, technological developments in both laparoscopic equipment and vascular sealing technologies have increased their popularity. Innovative features including integrated cutting and sealing capabilities, ergonomic designs, and improved energy delivery systems have considerably improved the effectiveness of vessel sealing devices.
Hospitals and specialty clinics represent the leading market segment
The rise in chronic diseases is a crucial factor driving the growth of hospitals and specialty clinics. As per Centers of Diseases Control and Prevention, an estimated 129 million people in the US have at least 1 major chronic disease such as heart disease, cancer, diabetes, obesity, hypertension. Moreover, five of the top 10 leading causes of death in the US are, or are strongly associated with, preventable and treatable chronic diseases. Over the past 2 decades prevalence has increased steadily, and this trend is expected to continue. Chronic conditions such as diabetes, hypertension, cancer, and respiratory diseases require ongoing medical attention, frequent monitoring, and specialized treatments. This has led to a surge in demand for healthcare services and facilities that can manage these conditions effectively. Specialty clinics focusing on diabetes care, oncology, cardiology, and pulmonology are expanding to meet the needs of patients with chronic diseases which in turn is escalating the vessel sealing devices demand.
North America leads the market, accounting for the largest vessel sealing devices market share
The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America was the largest regional market for vessel sealing devices.
North America, especially he United States, has one of the most advanced healthcare systems in the world. The 2021 World Index on Healthcare Innovation, conducted by the Foundation for Research on Equal Opportunity (FREOPP), ranked the United States in 6th place among the world's healthcare systems. The analysis finds that the United States is a global leader in scientific advancement but that our healthcare system is fiscally unsustainable. The availability of well-equipped hospitals, specialist surgical facilities, and clinics promotes the use of innovative medical technologies, such as vascular sealing devices. Besides, the region's healthcare system invests heavily in cutting-edge equipment and technology, allowing for high-quality surgical care. Moreover, the high healthcare spending, led by both the public and private sectors, enables significant investment in medical technologies and surgical innovations.